Tectonic Therapeutic, Inc. SEC filings TECX
Tectonic Therapeutic, Inc. has 582 filings in SEC EDGAR's recent list, going back to Aug 3, 2016. Its latest annual report, Form ARS, was filed on Apr 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (acquisition or sale of assets). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Jul 15, 2025 | — |
| CORRESP | Letter to the SEC | Jul 11, 2025 | — |
| UPLOAD | Letter from the SEC | Jul 10, 2025 | — |
| EFFECT | Filing | Jul 8, 2025 | — |
| EFFECT | Filing | Jul 8, 2025 | — |
| EFFECT | Filing | Apr 3, 2025 | — |
| EFFECT | Filing | Apr 2, 2025 | — |
| CORRESP | Letter to the SEC | Mar 31, 2025 | — |
| UPLOAD | Letter from the SEC | Mar 31, 2025 | — |
| D | Filing | Feb 14, 2025 | — |
| EFFECT | Filing | Jul 30, 2024 | — |
| CORRESP | Letter to the SEC | Jul 26, 2024 | — |
| UPLOAD | Letter from the SEC | Jul 26, 2024 | — |
| 425 | Filing | Jun 4, 2024 | — |
| 425 | Filing | Jun 3, 2024 | — |
| 425 | Filing | May 28, 2024 | — |
| 425 | Filing | May 21, 2024 | — |
| SEC STAFF LETTER | Filing | May 7, 2024 | — |
| EFFECT | Filing | May 3, 2024 | — |
| CORRESP | Letter to the SEC | May 2, 2024 | — |
| CORRESP | Letter to the SEC | Apr 29, 2024 | — |
| SEC STAFF LETTER | Filing | Apr 24, 2024 | — |
| UPLOAD | Letter from the SEC | Apr 24, 2024 | — |
| CORRESP | Letter to the SEC | Apr 15, 2024 | — |
| UPLOAD | Letter from the SEC | Apr 8, 2024 | — |
| 425 | Filing | Apr 4, 2024 | — |
| CORRESP | Letter to the SEC | Mar 25, 2024 | — |
| UPLOAD | Letter from the SEC | Mar 12, 2024 | — |
| 425 | Filing | Jan 30, 2024 | — |
| 425 | Filing | Jan 30, 2024 | — |
| 425 | Filing | Jan 30, 2024 | — |
| RW | Filing | Nov 3, 2023 | — |
| EFFECT | Filing | Jan 14, 2020 | — |
| CORRESP | Letter to the SEC | Jan 10, 2020 | — |
| CORRESP | Letter to the SEC | Jan 2, 2020 | — |
| UPLOAD | Letter from the SEC | Dec 27, 2019 | — |
| EFFECT | Filing | Jul 10, 2019 | — |
| CORRESP | Letter to the SEC | Jul 8, 2019 | — |
| UPLOAD | Letter from the SEC | Jul 3, 2019 | — |
| CT ORDER | Filing | Jun 21, 2018 | — |
| EFFECT | Filing | Jun 20, 2018 | — |
| CERT | Filing | Jun 19, 2018 | — |
| 8-A12B | Filing | Jun 18, 2018 | — |
| CORRESP | Letter to the SEC | Jun 18, 2018 | — |
| CORRESP | Letter to the SEC | Jun 18, 2018 | — |
| CORRESP | Letter to the SEC | Jun 15, 2018 | — |
| UPLOAD | Letter from the SEC | Jun 14, 2018 | — |
| UPLOAD | Letter from the SEC | Jun 12, 2018 | — |
| CORRESP | Letter to the SEC | Jun 1, 2018 | — |
| CORRESP | Letter to the SEC | May 25, 2018 | — |
| UPLOAD | Letter from the SEC | May 23, 2018 | — |
| DRSLTR | Filing | May 11, 2018 | — |
| DRS/A | Filing | May 11, 2018 | — |
| UPLOAD | Letter from the SEC | May 7, 2018 | — |
| DRS | Filing | Apr 6, 2018 | — |
| D | Filing | Feb 2, 2018 | — |
| D | Filing | Aug 3, 2016 | — |
Showing 57 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- TECX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- NY
- Headquarters
- Watertown, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1681087
- Former names
- AvroBio, Inc. (until Jun 18, 2024); AVROBIO, Inc. (until Jun 18, 2024)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.